Market Overview:
The global lower respiratory tract infection treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of lower respiratory tract infections, increasing awareness about available treatments, and growing demand for better and more effective therapies. The global lower respiratory tract infection treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into supportive care, hospital care, drugs, and vaccines. On the basis of application, the market is segmented into hospitals, clinics ambulatory surgical centers (ASCs), and others. The hospitals segment accounted for majority share in 2017 owing to high prevalence rate of LRTI across all regions coupled with rising number of hospital admissions for LRTI patients globally.
Product Definition:
Lower respiratory tract infection treatment is the use of medication and other therapies to treat an infection or inflammation of the lower respiratory tract. Lower respiratory tract infections (LRTIs) are a common cause of illness and death, particularly in infants, young children, and the elderly. Treatment for LRTIs may include antibiotics, antiviral agents, or bronchodilators depending on the cause of the infection. Early diagnosis and treatment is important for preventing serious complications.
Supportive Care:
Supportive care is medical intervention that helps to maintain or restore the body's functions and promote recovery from illness or injury. It includes management of complications, prevention of readmission, and providing nutrition when oral intake cannot be managed.
Hospital Care:
Hospital care is an important aspect in the treatment of lower respiratory tract infection. It includes management of acute symptoms such as fever, cough, and shortness of breath along with providing a general nursing care to the patients. In addition, it also provides diagnostic facilities for identification of specific infections and diseases.
Application Insights:
Based on application, the global LRTI treatment market is segmented into hospitals, clinics and ambulatory surgical centers, and others. Hospitals held the largest share in 2017 owing to factors such as a large patient base with LRTI infection and increasing prevalence of chronic respiratory diseases. According to estimates published by WHO in 2018, around 1 billion people suffer from chronic respiratory diseases globally which is expected to increase over the forecast period. This factor will drive demand for LRTI treatment during the forecast period.
The clinics & ambulatory surgical centers segment is anticipated to witness lucrative growth over the forecast period due largely to an increase in number of low-cost generic drugs being used for coughs & colds at relatively lower costs than compared with hospital care services across regions including North America and Europe Pacific region.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high disease burden, favorable reimbursement scenario, and increasing awareness levels amongst individuals. The U.S., which is at the forefront of this region, accounted for a large share of revenue generation owing to its well-developed healthcare sector and advanced medical infrastructure coupled with an efficient regulatory framework that ensures quality standards throughout the supply chain are some factors responsible for its dominance in this industry vertical.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income leading towards improved healthcare access by people living in developing countries such as India and China thereby fueling demand for treatment options within this region during 2018’s forecast period.
Growth Factors:
- Increasing incidence of respiratory infections: The increasing incidence of respiratory infections is one of the major growth drivers for the lower respiratory tract infection treatment market. According to a study by the Centers for Disease Control and Prevention (CDC), each year in the U.S., approximately 22 million people contract a respiratory infection, which leads to about 1 million hospitalizations and around 50,000 deaths.
- Growing awareness about lower respiratory tract infections: The growing awareness about lower respiratory tract infections among patients and healthcare professionals is another major growth driver for this market. This is because early diagnosis and treatment of these infections can help reduce their severity and improve patient outcomes.
- Rising demand for better-tolerated therapies: The rising demand for better-tolerated therapies is another key growth driver for this market as patients are increasingly looking for treatments that cause minimal side effects. This has led to an increase in the adoption of novel therapeutics such as monoclonal antibodies, which offer improved tolerability profiles over traditional antibiotics or antivirals used to treat lower respiratory tract infections..
- AstraZeneca announced that it will invest 0 million over five years into its R&D efforts targeting infectious diseases including pneumonia.. Such investments
Scope Of The Report
Report Attributes
Report Details
Report Title
Lower Respiratory Tract Infection Treatment Market Research Report
By Type
Supportive Care, Hospital Care, Drugs, Vaccines
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Others
By Companies
Sanofi Pasteur, Merck, GlaxoSmithKline, Pfizer, AstraZeneca
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Lower Respiratory Tract Infection Treatment Market Report Segments:
The global Lower Respiratory Tract Infection Treatment market is segmented on the basis of:
Types
Supportive Care, Hospital Care, Drugs, Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi Pasteur
- Merck
- GlaxoSmithKline
- Pfizer
- AstraZeneca
Highlights of The Lower Respiratory Tract Infection Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Supportive Care
- Hospital Care
- Drugs
- Vaccines
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lower Respiratory Tract Infection Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lower respiratory tract infection (LRTI) is a common illness that can be caused by a variety of viruses, bacteria, and fungi. Treatment typically involves antibiotics to kill the infection and relieve symptoms. In some cases, surgery may also be necessary to remove the infected tissue or fluid from the lungs.
Some of the key players operating in the lower respiratory tract infection treatment market are Sanofi Pasteur, Merck, GlaxoSmithKline, Pfizer, AstraZeneca.
The lower respiratory tract infection treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lower Respiratory Tract Infection Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lower Respiratory Tract Infection Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lower Respiratory Tract Infection Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lower Respiratory Tract Infection Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lower Respiratory Tract Infection Treatment Market Size & Forecast, 2020-2028
4.5.1 Lower Respiratory Tract Infection Treatment Market Size and Y-o-Y Growth
4.5.2 Lower Respiratory Tract Infection Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Supportive Care
5.2.2 Hospital Care
5.2.3 Drugs
5.2.4 Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lower Respiratory Tract Infection Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lower Respiratory Tract Infection Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Supportive Care
9.6.2 Hospital Care
9.6.3 Drugs
9.6.4 Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Supportive Care
10.6.2 Hospital Care
10.6.3 Drugs
10.6.4 Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Supportive Care
11.6.2 Hospital Care
11.6.3 Drugs
11.6.4 Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Supportive Care
12.6.2 Hospital Care
12.6.3 Drugs
12.6.4 Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Supportive Care
13.6.2 Hospital Care
13.6.3 Drugs
13.6.4 Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lower Respiratory Tract Infection Treatment Market: Competitive Dashboard
14.2 Global Lower Respiratory Tract Infection Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi Pasteur
14.3.2 Merck
14.3.3 GlaxoSmithKline
14.3.4 Pfizer
14.3.5 AstraZeneca
